Professional Records
Medicine Doctors
Fei Zhang
View pageSpecialties:
Psychiatry
Fei Zhang Phones & Addresses
-
6 Donna Dr, Edison, NJ 08820 (732) 549-1787 (732) 516-1704
-
58 Prestwick Way, Edison, NJ 08820 (732) 549-6065
-
North Brunswick, NJ
-
Monroe Township, NJ
-
536 113Th St, New York, NY 10025 (212) 666-2915
-
536 W 113Th St #24, New York, NY 10025 (212) 666-2915
-
Melvindale, MI
-
Scotch Plains, NJ
-
Atlanta, GA
-
Smyrna, GA
-
South Plainfield, NJ
Specialities
Buyer's Agent • Listing Agent
Resumes
Resumes
Fei Zhang
View page
Fei Zhang
View page
Fei Zhang
View page
Manager At Amgen
View pagePosition:
manager at amgen
Location:
United States
Industry:
Computer Hardware
Work:
amgen
manager
manager
Student At New York University - Leonard N. Stern School Of Business
View pageLocation:
Greater New York City Area
Industry:
Financial Services
Fei Zhang
View pageLocation:
United States
Buyer At Loreal
View pageLocation:
United States
Industry:
Cosmetics
Fei Zhang
View pageLocation:
United States
Business Records
Name / Title
Company / Classification
Phones & Addresses
American Hawks LLC
Whol Sporting/Recreational Goods
Whol Sporting/Recreational Goods
150 Maple Ave, South Plainfield, NJ 07080
58 Prestwick Way, Edison, NJ 08820
58 Prestwick Way, Edison, NJ 08820
Publications
Us Patents
Tartaric Acid Salts Of A Dipeptidyl Peptidase-Iv Inhibitor
View pageUS Patent:
20090124601, May 14, 2009
Filed:
Mar 24, 2006
Appl. No.:
11/883907
Inventors:
Zhiguo J. Song - Edison NJ, US
Fei Zhang - Edison NJ, US
Rebecca Leigh Shultz - Maplewood NJ, US
Fei Zhang - Edison NJ, US
Rebecca Leigh Shultz - Maplewood NJ, US
International Classification:
A61K 31/551
C07D 223/10
C07D 223/10
US Classification:
514218, 540529
Abstract:
Tartaric acid salts of (3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl) butanoyl]hexahydro-3-(2,2,2-trifluoroethyl)-2H-1,4-diazepin-2-one are potent inhibitors of dipeptidyl peptidase-IV and are useful for the prevention and/or treatment of non-insulin dependent diabetes mellitus, also referred to as Type 2 diabetes. The invention also relates to crystalline anhydrate forms of the tartaric acid salts as well as a process for their preparation, pharmaceutical compositions containing these novel forms and methods of use for the treatment of Type 2 diabetes.